PhyllodesTumorBrachytherapyChemopreventionCytotoxicMultimodalityTherapyRadiotherapyPalpationAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCyclophosphamideFlowCytometryCytostaticCystApoptosisChemotherapySelf-examinationDoseDenseTherapyAntiemeticsEstrogen/EstradiolEGFRAbsoluteRiskDimplingMorpheaAyurvedaOvarianSuppressionLymphoscintigraphyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55BRCAGeneMRIAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCalcificationsIntraductalPapillomaTriple +/-BreastCancerBevacizumabKappaEpsilonRADHormoneReplacementTherapyMastodyniaSERMAnastrozolePaclitaxelGuaranteedRenewableInsuranceRaloxifeneBI-RADSBOCAOligometastasesCDK4/6InhibitorsCapecitabineDefinitiveSurgeryDocetaxelGermlineMutationER+/-BreastCancerFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.MegestrolAcetateImmunotherapyPrecisionMedicineLapatinibAdvocacyMethotrexateGailModelCachexiaKi-67RateCMFChemotherapyGeneticPredispositionPhysicalactivity mayreduce therisk of breastcancersAdenocarcinomaMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltmTORInhibitorsLumpECOGScoreWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AlopeciaStaging1 in 8womenFamilyHistoryAromataseInhibitorsDown-StagingWomen ages40+ shouldhave a clinicalbreast examat least yearlyACChemotherapyTyrosine-KinaseInhibitorBilateralProphylacticMastectomyCAMAntibodyTherapyFibroadenomaPARPInhibitorsLumpectomyBreastTomosynthesisCo-survivorHerceptinMastectomyHormoneReceptorStatusMultifocalTumorsBiopsyTamoxifenDoxorubicinGeneticCounselingFISHAngiogenesisCheckpointInhibitorAdjuvantTherapyGeneMutationProgestinTumorGradeLCISPI3KinaseInhibitorsRelapsePagetDiseaseHER-25-FluorouracilLymphNodeStatusPathologicResponseEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMetastasisIn-situCarcinomaNeoadjuvantTherapyPalbociclibPhyllodesTumorBrachytherapyChemopreventionCytotoxicMultimodalityTherapyRadiotherapyPalpationAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCyclophosphamideFlowCytometryCytostaticCystApoptosisChemotherapySelf-examinationDoseDenseTherapyAntiemeticsEstrogen/EstradiolEGFRAbsoluteRiskDimplingMorpheaAyurvedaOvarianSuppressionLymphoscintigraphyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55BRCAGeneMRIAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCalcificationsIntraductalPapillomaTriple +/-BreastCancerBevacizumabKappaEpsilonRADHormoneReplacementTherapyMastodyniaSERMAnastrozolePaclitaxelGuaranteedRenewableInsuranceRaloxifeneBI-RADSBOCAOligometastasesCDK4/6InhibitorsCapecitabineDefinitiveSurgeryDocetaxelGermlineMutationER+/-BreastCancerFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.MegestrolAcetateImmunotherapyPrecisionMedicineLapatinibAdvocacyMethotrexateGailModelCachexiaKi-67RateCMFChemotherapyGeneticPredispositionPhysicalactivity mayreduce therisk of breastcancersAdenocarcinomaMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltmTORInhibitorsLumpECOGScoreWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AlopeciaStaging1 in 8womenFamilyHistoryAromataseInhibitorsDown-StagingWomen ages40+ shouldhave a clinicalbreast examat least yearlyACChemotherapyTyrosine-KinaseInhibitorBilateralProphylacticMastectomyCAMAntibodyTherapyFibroadenomaPARPInhibitorsLumpectomyBreastTomosynthesisCo-survivorHerceptinMastectomyHormoneReceptorStatusMultifocalTumorsBiopsyTamoxifenDoxorubicinGeneticCounselingFISHAngiogenesisCheckpointInhibitorAdjuvantTherapyGeneMutationProgestinTumorGradeLCISPI3KinaseInhibitorsRelapsePagetDiseaseHER-25-FluorouracilLymphNodeStatusPathologicResponseEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearMetastasisIn-situCarcinomaNeoadjuvantTherapyPalbociclib

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. Phyllodes Tumor
  2. Brachytherapy
  3. Chemoprevention
  4. Cytotoxic
  5. Multimodality Therapy
  6. Radiotherapy
  7. Palpation
  8. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  9. Cyclophosphamide
  10. Flow Cytometry
  11. Cytostatic
  12. Cyst
  13. Apoptosis
  14. Chemotherapy
  15. Self-examination
  16. Dose Dense Therapy
  17. Antiemetics
  18. Estrogen/Estradiol
  19. EGFR
  20. Absolute Risk
  21. Dimpling
  22. Morphea
  23. Ayurveda
  24. Ovarian Suppression
  25. Lymphoscintigraphy
  26. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  27. BRCA Gene
  28. MRI
  29. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  30. Calcifications
  31. Intraductal Papilloma
  32. Triple +/- Breast Cancer
  33. Bevacizumab
  34. Kappa Epsilon
  35. RAD
  36. Hormone Replacement Therapy
  37. Mastodynia
  38. SERM
  39. Anastrozole
  40. Paclitaxel
  41. Guaranteed Renewable Insurance
  42. Raloxifene
  43. BI-RADS
  44. BOCA
  45. Oligometastases
  46. CDK4/6 Inhibitors
  47. Capecitabine
  48. Definitive Surgery
  49. Docetaxel
  50. Germline Mutation
  51. ER +/-
  52. Breast Cancer
  53. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  54. Megestrol Acetate
  55. Immunotherapy
  56. Precision Medicine
  57. Lapatinib
  58. Advocacy
  59. Methotrexate
  60. Gail Model
  61. Cachexia
  62. Ki-67 Rate
  63. CMF Chemotherapy
  64. Genetic Predisposition
  65. Physical activity may reduce the risk of breast cancers
  66. Adenocarcinoma
  67. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  68. mTOR Inhibitors
  69. Lump
  70. ECOG Score
  71. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  72. Alopecia
  73. Staging
  74. 1 in 8 women
  75. Family History
  76. Aromatase Inhibitors
  77. Down-Staging
  78. Women ages 40+ should have a clinical breast exam at least yearly
  79. AC Chemotherapy
  80. Tyrosine-Kinase Inhibitor
  81. Bilateral Prophylactic Mastectomy
  82. CAM
  83. Antibody Therapy
  84. Fibroadenoma
  85. PARP Inhibitors
  86. Lumpectomy
  87. Breast Tomosynthesis
  88. Co-survivor
  89. Herceptin
  90. Mastectomy
  91. Hormone Receptor Status
  92. Multifocal Tumors
  93. Biopsy
  94. Tamoxifen
  95. Doxorubicin
  96. Genetic Counseling
  97. FISH
  98. Angiogenesis
  99. Checkpoint Inhibitor
  100. Adjuvant Therapy
  101. Gene Mutation
  102. Progestin
  103. Tumor Grade
  104. LCIS
  105. PI3 Kinase Inhibitors
  106. Relapse
  107. Paget Disease
  108. HER-2
  109. 5-Fluorouracil
  110. Lymph Node Status
  111. Pathologic Response
  112. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  113. Metastasis
  114. In-situ Carcinoma
  115. Neoadjuvant Therapy
  116. Palbociclib